• 제목/요약/키워드: diode laser

검색결과 1,017건 처리시간 0.026초

접합 온도를 고려한 TO-CAN 레이저 다이오드의 Screening 조건 연구 (Study on junction temperature characteristics of TO-CAN laser diode for optimized screening tests)

  • 이동수
    • 조명전기설비학회논문지
    • /
    • 제16권6호
    • /
    • pp.126-129
    • /
    • 2002
  • 레이저 다이오드의 동작 수명을 예측하고 안정화된 성능과 신뢰도를 만족하기 위해서는 검증된 시스템으로 광부품의 신뢰성 테스트를 수행하는 것이 중요하다. 본 연구에서는 온도와 인가 전류에 따른 접합 온도(junction temperature) 특성을 관찰하여 실제 주위 온도 ( $T_{A}$)와 광소자의 온도( $T_{j}$) 차이를 이론 및 실험 적으로 도출하였고, 이를 토대로 정밀한 burn-in 테스트를 위한 screening 조건을 설정해 제시하였다.하였다.

Bidirectional 1.25-Gbps WDM-PON with Broadcasting Function Using A Fabry-Perot Laser Diode and RSOA

  • Pham, Thang T.;Kim, Hyun-Seung;Won, Yong-Yuk;Han, Sang-Kook
    • Journal of the Optical Society of Korea
    • /
    • 제12권4호
    • /
    • pp.359-363
    • /
    • 2008
  • A novel WDM-PON system delivering bidirectional 1.25-Gbps data and broadcasting data is proposed. A subcarrier signal modulates optical carriers of a Fabry-Perot-laser-diode based broadband light source to broadcast to all users. Reflective semiconductor optical amplifiers are used as modulators for the baseband data at both the optical line terminal and the remote optical network unit for a channel. Bit error rate and error vector magnitude were measured to demonstrate the proposed scheme.

광역학적 암치료를 위한 635nm 다이오드 레이저 시스템 개발 (The Development of 63nm Diode Laser System for Photodynamic Therapy of Cancer)

  • 임현수
    • 대한의용생체공학회:의공학회지
    • /
    • 제24권4호
    • /
    • pp.319-328
    • /
    • 2003
  • 본 논문은 광역학적 암치료를 위한 광원장치의 개발로서 반도체 다이오드 레이저를 이용한 의료용 레이저 시스템의 개발이 목적이다. 광역학적 암 치료에서 이상적인 광원장치는 초점크기를 조절할 수 있으면서 발산하지 않는 균일한 빛과 특정 파장대의 안정성을 갖는 것이다. 본 연구에서는 이러한 점을 고려하여 635nm 파장대의 다이오드 공진기를 이용하였으며, 개발된 레이저 시스템은 제어장치를 사용하여 정교하고 안정적인 출력을 가지도록 하였으며, 시스템은 사용자의 편리성을 고려하여 소형화하였다. 다이오드 레이저시스템의 펄스 형태의 발진모드에서는 초기의 돌입전류에 의해 공진기를 파손시킬 수 있으므로 본 연구에서는 이러한 현상을 회로적으로 보완하여 msec 단위로 on/off 할 경우에도 공진기에 전혀 손상을 입히지 않도록 설계를 하였다. 임상의가 편리하게 방사시간을 설정하고, 연속출력. 펄스. 버스트 펄스, 슈퍼펄스를 방사할 수 있도록 고안하여. 다양한 암조직의 상태에 따라 치료할 수 있도록 구현하였다. 실험결과 레이저의 출력은 입력전류와 시간에 따라 10mW에서 300mW 까지 선형적으로 증가함을 보였다. 개발된 광역학적 레이저 시스템은 고속제어가 가능하고 정 전류 제어와 효과적인 냉각 제어를 통해 안정적으로 정확하게 출력할 수 있었다.

수종의 레이저로 임프란트 표면 처리 시 표면 형태의 변화에 대한 주사전자 및 주사탐침 현미경적 연구 (The SEM and SPM Study on the Change of Machined Titanium Implant Surface following Various Laser Treatments)

  • 김인경;정진형;임성빈
    • Journal of Periodontal and Implant Science
    • /
    • 제31권2호
    • /
    • pp.451-463
    • /
    • 2001
  • Following the extensive use of implant, the incidence of peri-implantitis increases. Guided bone regeneration has been used for the optimal treatment of this disease. Because implant surface was contaminated with plaque and calculus, cleaning and detoxification were needed for the reosseointegration when guided bone regeneration was performed. Various mechanical and chemical methods have been used for cleaning and detoxification of implant surface, air-powder abrasive and oversaturated citrate were known to be most effective among these methods. However, these methods were incomplete because these could not thoroughly remove bacteria of implant surface, moreover deformed implant surface. Recent studies for detoxification of the implant surface using laser were going on, $CO_2$ laser and Soft Diode laser were known to be effective among these methods. The purpose of this study was to obtain clinical guide by application these laser to implant surface. 15 experimental machined pure titanium cylinder models were fabricated. The $CO_2$ laser treatment under dry, wet and hydrogen peroxide condition or the Soft Diode laser treatment under Toluidine blue O solution condition was performed on the each of models. Each groups were examined with SPM and SEM to know whether their surface was changed. The results were as follows : 1. Surface roughness and surface form weren't changed when $CO_2$ laser was usedunder dry condition(P>0.05). 2. Surface roughness and surface form weren't changed when $CO_2$ laser was used under wet condition(P>0.05). 3. Surface roughness and surface form weren't changed when $CO_2$ laser was used under hydrogen peroxide condition(P>0.05). 4. Surface roughness and surface form weren't changed when Soft Diode laser was used under toluidine blue O solution condition(P>0.05). From the result of this study, it may be concluded that the $CO_2$ laser having relatively safe pulse mode and the Soft Diode laser used with photosensitizer can be used safely to treat peri-implantitis.

  • PDF

In Vivo Enhanced Indocyanine Green-Photothermal Therapy for a Subconjunctival Tumor

  • Kim, Chang Zoo;Lee, Sang Joon;Hwang, Sang Seok;Chae, Yu-Gyeong;Kwon, Daa Young;Ko, Taek Yong;Kim, Jun Hyeong;Jung, Min Jung;Masanganise, Rangarirai;Oak, Chulho;Ahn, Yeh-Chan
    • Current Optics and Photonics
    • /
    • 제5권3호
    • /
    • pp.311-321
    • /
    • 2021
  • Indocyanine green (ICG) is a dye approved for use in clinical diagnostics. ICG remains in the intravascular space following intravenous administration, due to its ability to rapidly bind to the plasma proteins, and its therapeutic potential has been studied in well-vascularized cutaneous tumors. Here we have evaluated the clinical response of a subconjunctival tumor to photothermal therapy (PTT) using an ICG-enhanced near-infrared diode laser and its adverse effects, in a rabbit. 22 male New Zealand white rabbits with subconjunctival tumors were enrolled (control group 6, laser-only group 8, laser-with-ICG group 8). Rabbits in the laser-with-ICG group received ICG (twice, 2 mg/kg each time, intravenously) directly followed by irradiation with a diode laser (λ = 810 nm). Rabbits in the laser-only group were irradiated with the diode laser. ICG angiography, ultrasonography, and pathologic examination were performed to evaluate PTT response at specific time points (0, 2, and 4 weeks after PTT). Two weeks after initial treatment, the eight rabbits treated by laser with ICG showed a 100% response rate. There was no clinical response in both laser-only and control groups. ICG-PTT is a potential and effective palliative therapeutic modality for subconjunctival tumors.